FDA
-
-
-
-
-
-
-
Absci accelerates hair loss drug trial, schedules expert seminar
-
-
-
-
-
-
-
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

